Related Experiment Video
Updated: Mar 28, 2026

Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
Constantijn Franssen1, Sophia Chen1, Andreas Unger2
1Department of Physiology, Institute for Cardiovascular Research, VU University Medical Center, Amsterdam, the Netherlands.
Insights
Metabolic risk causes heart failure with preserved ejection fraction (HFpEF) through inflamed coronary microvascular endothelial activation. This impairs nitric oxide (NO) signaling to heart cells, increasing stiffness and hypertrophy.
Area of Science:
- Cardiovascular Medicine
- Molecular Biology
- Pathophysiology
Background:
- Metabolic risk factors are linked to diastolic left ventricular (LV) dysfunction.
- Diastolic LV dysfunction is a hallmark of heart failure with preserved ejection fraction (HFpEF).
Purpose of the Study:
- To investigate if metabolic risk-induced, low-grade inflammation contributes to HFpEF.
- To explore the role of coronary microvascular endothelial activation in this process.
- To determine the impact on cardiomyocyte signaling, hypertrophy, and diastolic stiffness.
Main Methods:
- Examined inflammatory endothelial activation in myocardial biopsies from HFpEF patients.
- Assessed oxidative stress, nitric oxide (NO) bioavailability, and cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) signaling.
- Validated findings in obese Zucker diabetic fatty/Spontaneously hypertensive heart failure F1 hybrid (ZSF1)-HFpEF rats compared to controls.
Main Results:
- Upregulated E-selectin and intercellular adhesion molecule-1 expression in HFpEF myocardium.
- Increased NADPH oxidase 2 expression in macrophages and endothelial cells, not cardiomyocytes.
- Uncoupled endothelial nitric oxide synthase with reduced myocardial nitrite/nitrate, cGMP, and PKG activity.
Conclusions:
- HFpEF is associated with coronary microvascular endothelial activation and oxidative stress.
- These factors reduce NO-dependent signaling from endothelial cells to cardiomyocytes.
- This impaired signaling contributes to cardiomyocyte stiffness and hypertrophy in HFpEF.
Objectives:
The present study investigated whether systemic, low-grade inflammation of metabolic risk contributed to diastolic left ventricular (LV) dysfunction and heart failure with preseved ejection fraction (HFpEF) through coronary microvascular endothelial activation, which alters paracrine signalling to cardiomyocytes and predisposes them to hypertrophy and high diastolic stiffness.
Background:
Metabolic risk is associated with diastolic LV dysfunction and HFpEF.
Methods:
We explored inflammatory endothelial activation and its effects on oxidative stress, nitric oxide (NO) bioavailability, and cyclic guanosine monophosphate (cGMP)-protein kinase G (PKG) signalling in myocardial biopsies of HFpEF patients and validated our findings by comparing obese Zucker diabetic fatty/Spontaneously hypertensive heart failure F1 hybrid (ZSF1)-HFpEF rats to ZSF1-Control (Ctrl) rats.
Results:
In myocardium of HFpEF patients and ZSF1-HFpEF rats, we observed the following: 1) E-selectin and intercellular adhesion molecule-1 expression levels were upregulated; 2) NADPH oxidase 2 expression was raised in macrophages and endothelial cells but not in cardiomyocytes; and 3) uncoupling of endothelial nitric oxide synthase, which was associated with reduced myocardial nitrite/nitrate concentration, cGMP content, and PKG activity.
Conclusions:
HFpEF is associated with coronary microvascular endothelial activation and oxidative stress. These lead to a reduction of NO-dependent signalling from endothelial cells to cardiomyocytes, which can contribute to the high cardiomyocyte stiffness and hypertrophy observed in HFpEF.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Myocarditis I: Introduction
Heart Failure I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Coronary Artery Disease II: Pathophysiology